| founder and ex-CEO | |
| Company | Across Health |
|---|---|
| Industry | Healthcare |
| Specialties | Go-to-Market Strategy , Biopharma Market Entry , Healthcare Data Products , Evidence-Based Strategy , Healthcare Innovation |
| Rate | EUR 300/hr |
| Book on TinRate | |
fonny schenck is a founder and ex-ceo at Across Health. fonny schenck is recognized as an expert in Go-to-Market Strategy, Biopharma Market Entry, Healthcare Data Products. Founder and ex-CEO of Across Health, specializing in evidence-based go-to-market models for biopharma and scaling actionable data products.
Fonny Schenck is the founder and former CEO of Across Health, a company focused on healthcare industry solutions. Throughout their career, Schenck has developed deep expertise in creating and implementing evidence-based go-to-market strategies specifically tailored for the biopharmaceutical industry.
Schenck's primary area of expertise lies in developing evidence-based go-to-market models for the biopharma sector. This specialized knowledge encompasses understanding the unique challenges and regulatory requirements that pharmaceutical companies face when bringing new products to market. Their approach emphasizes the use of data-driven methodologies to ensure that market entry strategies are grounded in solid evidence and analytics.
In addition to go-to-market strategy, Schenck has significant experience in scaling actionable data products. This expertise involves transforming raw data into meaningful insights that can drive business decisions and improve market outcomes. Their work focuses on creating data solutions that not only provide valuable information but can also be implemented effectively at scale within healthcare organizations.
As the founder of Across Health, Schenck has been instrumental in bridging the gap between healthcare innovation and market implementation. Their work has contributed to helping biopharmaceutical companies navigate the complex landscape of product launches and market penetration strategies. The evidence-based approach they champion has become increasingly important in an industry where regulatory compliance and clinical validation are paramount.
Schenck's leadership experience as CEO has provided them with a comprehensive understanding of both the strategic and operational aspects of running a healthcare-focused business. This combination of entrepreneurial experience and deep industry knowledge positions them as a valuable resource for organizations looking to optimize their market entry strategies and data utilization practices.
Fonny Schenck has transitioned from founder and CEO of Across Health to Strategic Management Advisor to Across Health and EVP Precision Value & Health following the acquisition by Precision Value & Health in June 2024. Previously worked at Johnson & Johnson leading European programmes for salesforce effectiveness, CRM business strategy and digital marketing.
| Full name | fonny schenck |
| Role | founder and ex-CEO |
| Organization | Across Health |
| Industry | Healthcare |
| Specialties | Go-to-Market Strategy · Biopharma Market Entry · Healthcare Data Products · Evidence-Based Strategy · Healthcare Innovation |
| Consulting rate | EUR 300 per hour |
| Bookable | Yes — via TinRate |
| Expert | Role | Country | Rate | Languages |
|---|---|---|---|---|
| Alexander Synhaeve | Founder & CEO, Tomorrow.be | Belgium | EUR 170/hr | |
| Benedicte De Jaeger | Orthomoleculair hormooncoach, Benevida | Belgium | EUR 100/hr | |
| Brecht Vandewaetere | Building systems for business ànd personal growth, monrō | Belgium | EUR 275/hr | en, nl |
| Carl Dieryckx | Digital strategist for sales & marketing teams, Indie Group | Belgium | EUR 180/hr | en, fr, nl |
| Damien Rapoye | Tech, SaaS, Gaming & Manufacturing | Complex Deals & International Expansion, Elevate Advisory & Management | EUR 145/hr | ||
| Dieter Roman | Commercial Director | EUR 150/hr |